Mitral Valve Disease
The ACTIVE Trial is a prospective, randomized, multicenter trial. Patients with clinically significant functional mitral regurgitation will be randomized 2:1 to receive either transcatheter mitral valve repair with the Edwards Cardioband System plus guideline directed medical therapy (GDMT) or GDMT alone. Patients will be seen for follow-up visits at discharge, 30 days, 6 months, and annually through 5 years.
Principal Investigator: Robert L. Smith, II, MD
Locations: Baylor Scott & White The Heart Hospital – Plano
Sponsor: Edwards Lifesciences
IRB Number: 017-150
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: Participating may change your care
Brittany Zingler, RN469.814.4737Brittany.Zingler@BSWHealth.org
Necole Kell, RN469.814.4871Necole.Kell@BSWHealth.org
Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE)
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Health Care System's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Health Care System.